Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells

G. Corona, G. Toffoli, M. Fabris, A. Viel, A. Zarrelli, C. Donada, M. Boiocchi

Research output: Contribution to journalArticle

Abstract

The major role of the high-affinity folate-binding protein (FBP) is to regulate cellular folate homeostasis by increasing folate uptake in case of extracellular and intracellular folate deficiency. On this basis, we hypothesised that the overexpression of FBP in ovarian carcinoma might be physiologically associated with folate deficiency in the extracellular fluids, where ovarian carcinoma cells develop in vivo, or it might be the result of a reduced intracellular regeneration of the 5- methyltetrahydrofolate (5-CH3H4 folate). To test these hypotheses, we determined the bioavailability of folate in serum and in ascitic/cystic fluids of ovarian carcinoma patients (n=36). The intracellular shortage of 5- CH3H4 folate was evaluated in the extracellular fluids by measuring the concentration of homocysteine (Hcy), which is a useful marker of intracellular folate deficiency. Patients with ascites from malignant and benign non-ovarian pathologies were used as controls (n = 30). We found no folate shortage in the serum and ascitic/cystic fluids of ovarian carcinoma patients. The folate concentration was within the normal range and superimposable on that observed in serum and ascites of control patients. However, the ascitic/cystic Hcy concentration was significantly higher (P3H4 folate. This suggests a possible association between FBP overexpression and a biochemical defect of the cellular folate metabolism involved in the methionine cycle.

Original languageEnglish
Pages (from-to)1284-1290
Number of pages7
JournalEuropean Journal of Cancer
Volume33
Issue number8
DOIs
Publication statusPublished - Jul 1997

Fingerprint

Ascitic Fluid
Homocysteine
Menstrual Cycle
Folic Acid
Methionine
Carcinoma
Carrier Proteins
Extracellular Fluid
Ascites
Serum
Biological Availability
Regeneration

Keywords

  • 10- methylenetetrahydrofolate reductase
  • Enzyme defect
  • Folate
  • Folate-binding protein
  • Methylation process

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells. / Corona, G.; Toffoli, G.; Fabris, M.; Viel, A.; Zarrelli, A.; Donada, C.; Boiocchi, M.

In: European Journal of Cancer, Vol. 33, No. 8, 07.1997, p. 1284-1290.

Research output: Contribution to journalArticle

@article{80d3d572a2c94b42a38afaeb3df44d6e,
title = "Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells",
abstract = "The major role of the high-affinity folate-binding protein (FBP) is to regulate cellular folate homeostasis by increasing folate uptake in case of extracellular and intracellular folate deficiency. On this basis, we hypothesised that the overexpression of FBP in ovarian carcinoma might be physiologically associated with folate deficiency in the extracellular fluids, where ovarian carcinoma cells develop in vivo, or it might be the result of a reduced intracellular regeneration of the 5- methyltetrahydrofolate (5-CH3H4 folate). To test these hypotheses, we determined the bioavailability of folate in serum and in ascitic/cystic fluids of ovarian carcinoma patients (n=36). The intracellular shortage of 5- CH3H4 folate was evaluated in the extracellular fluids by measuring the concentration of homocysteine (Hcy), which is a useful marker of intracellular folate deficiency. Patients with ascites from malignant and benign non-ovarian pathologies were used as controls (n = 30). We found no folate shortage in the serum and ascitic/cystic fluids of ovarian carcinoma patients. The folate concentration was within the normal range and superimposable on that observed in serum and ascites of control patients. However, the ascitic/cystic Hcy concentration was significantly higher (P3H4 folate. This suggests a possible association between FBP overexpression and a biochemical defect of the cellular folate metabolism involved in the methionine cycle.",
keywords = "10- methylenetetrahydrofolate reductase, Enzyme defect, Folate, Folate-binding protein, Methylation process",
author = "G. Corona and G. Toffoli and M. Fabris and A. Viel and A. Zarrelli and C. Donada and M. Boiocchi",
year = "1997",
month = "7",
doi = "10.1016/S0959-8049(97)00121-4",
language = "English",
volume = "33",
pages = "1284--1290",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "8",

}

TY - JOUR

T1 - Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells

AU - Corona, G.

AU - Toffoli, G.

AU - Fabris, M.

AU - Viel, A.

AU - Zarrelli, A.

AU - Donada, C.

AU - Boiocchi, M.

PY - 1997/7

Y1 - 1997/7

N2 - The major role of the high-affinity folate-binding protein (FBP) is to regulate cellular folate homeostasis by increasing folate uptake in case of extracellular and intracellular folate deficiency. On this basis, we hypothesised that the overexpression of FBP in ovarian carcinoma might be physiologically associated with folate deficiency in the extracellular fluids, where ovarian carcinoma cells develop in vivo, or it might be the result of a reduced intracellular regeneration of the 5- methyltetrahydrofolate (5-CH3H4 folate). To test these hypotheses, we determined the bioavailability of folate in serum and in ascitic/cystic fluids of ovarian carcinoma patients (n=36). The intracellular shortage of 5- CH3H4 folate was evaluated in the extracellular fluids by measuring the concentration of homocysteine (Hcy), which is a useful marker of intracellular folate deficiency. Patients with ascites from malignant and benign non-ovarian pathologies were used as controls (n = 30). We found no folate shortage in the serum and ascitic/cystic fluids of ovarian carcinoma patients. The folate concentration was within the normal range and superimposable on that observed in serum and ascites of control patients. However, the ascitic/cystic Hcy concentration was significantly higher (P3H4 folate. This suggests a possible association between FBP overexpression and a biochemical defect of the cellular folate metabolism involved in the methionine cycle.

AB - The major role of the high-affinity folate-binding protein (FBP) is to regulate cellular folate homeostasis by increasing folate uptake in case of extracellular and intracellular folate deficiency. On this basis, we hypothesised that the overexpression of FBP in ovarian carcinoma might be physiologically associated with folate deficiency in the extracellular fluids, where ovarian carcinoma cells develop in vivo, or it might be the result of a reduced intracellular regeneration of the 5- methyltetrahydrofolate (5-CH3H4 folate). To test these hypotheses, we determined the bioavailability of folate in serum and in ascitic/cystic fluids of ovarian carcinoma patients (n=36). The intracellular shortage of 5- CH3H4 folate was evaluated in the extracellular fluids by measuring the concentration of homocysteine (Hcy), which is a useful marker of intracellular folate deficiency. Patients with ascites from malignant and benign non-ovarian pathologies were used as controls (n = 30). We found no folate shortage in the serum and ascitic/cystic fluids of ovarian carcinoma patients. The folate concentration was within the normal range and superimposable on that observed in serum and ascites of control patients. However, the ascitic/cystic Hcy concentration was significantly higher (P3H4 folate. This suggests a possible association between FBP overexpression and a biochemical defect of the cellular folate metabolism involved in the methionine cycle.

KW - 10- methylenetetrahydrofolate reductase

KW - Enzyme defect

KW - Folate

KW - Folate-binding protein

KW - Methylation process

UR - http://www.scopus.com/inward/record.url?scp=0030849277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030849277&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(97)00121-4

DO - 10.1016/S0959-8049(97)00121-4

M3 - Article

C2 - 9301457

AN - SCOPUS:0030849277

VL - 33

SP - 1284

EP - 1290

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 8

ER -